Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$179.87 - $225.13 $899 - $1,125
-5 Reduced 0.23%
2,130 $383,000
Q2 2023

Aug 14, 2023

SELL
$178.3 - $266.78 $16,403 - $24,543
-92 Reduced 4.13%
2,135 $380,000
Q1 2023

Aug 14, 2023

BUY
$215.53 - $274.5 $19,828 - $25,254
92 Added 4.31%
2,227 $479,000
Q1 2023

May 15, 2023

BUY
$215.53 - $274.5 $3,448 - $4,392
16 Added 0.72%
2,227 $479,000
Q4 2022

Feb 14, 2023

SELL
$125.51 - $229.3 $33,260 - $60,764
-265 Reduced 10.7%
2,211 $486,000
Q3 2022

Nov 14, 2022

SELL
$131.8 - $202.24 $30,314 - $46,515
-230 Reduced 8.5%
2,476 $334,000
Q2 2022

Aug 11, 2022

SELL
$121.11 - $216.05 $30,761 - $54,876
-254 Reduced 8.58%
2,706 $438,000
Q1 2022

May 16, 2022

BUY
$146.52 - $269.56 $21,098 - $38,816
144 Added 5.11%
2,960 $558,000
Q4 2021

Feb 14, 2022

SELL
$248.56 - $389.34 $27,093 - $42,438
-109 Reduced 3.73%
2,816 $763,000
Q3 2021

Nov 15, 2021

BUY
$249.6 - $403.14 $23,212 - $37,492
93 Added 3.28%
2,925 $1.06 Million
Q2 2021

Aug 13, 2021

BUY
$292.75 - $367.01 $41,277 - $51,748
141 Added 5.24%
2,832 $972,000
Q1 2021

May 14, 2021

BUY
$260.64 - $382.12 $10,425 - $15,284
40 Added 1.51%
2,691 $937,000
Q4 2020

Feb 17, 2021

BUY
$221.31 - $316.61 $586,692 - $839,333
2,651 New
2,651 $685,000

Others Institutions Holding BGNE

About BeiGene, Ltd.


  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $18.6B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.